Literature DB >> 16080197

Innate immune recognition of nucleic acids: beyond toll-like receptors.

Ken J Ishii1, Shizuo Akira.   

Abstract

During infection or tissue damage, the innate immune system detects and responds to nucleic acids released from pathogens or damaged host cells. Accumulating evidence has showed that specific sequences, modifications or structures of nucleic acids influence their immunomodulatory activities. Resulting innate immune modulations are regulated by Toll-like receptor (TLR)-dependent or -independent signaling pathways. The first step in host defense against foreign or unwelcome self nucleic acids may play important roles in immune responses against infectious organisms, as well as in clearance of unnecessary tissues, which may be linked to autoimmune diseases and possibly to other immunological disorders. Elucidating mechanisms of innate immune activation by nucleic acids will help future development of more efficient or safer nucleic acid-based immunotherapies and gene therapies. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16080197     DOI: 10.1002/ijc.21402

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  Cytosolic DNA-activated human dendritic cells are potent activators of the adaptive immune response.

Authors:  Katalin Kis-Toth; Attila Szanto; To-Ha Thai; George C Tsokos
Journal:  J Immunol       Date:  2011-06-27       Impact factor: 5.422

Review 2.  Update on toll-like receptor ligands and allergy: implications for immunotherapy.

Authors:  Anthony A Horner
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

Review 3.  Recognition of cytosolic DNA by cGAS and other STING-dependent sensors.

Authors:  Numana Bhat; Katherine A Fitzgerald
Journal:  Eur J Immunol       Date:  2014-01-13       Impact factor: 5.532

Review 4.  Toll or toll-free adjuvant path toward the optimal vaccine development.

Authors:  Ken J Ishii; Shizuo Akira
Journal:  J Clin Immunol       Date:  2007-03-17       Impact factor: 8.317

5.  Herpes Simplex Virus 1 UL24 Abrogates the DNA Sensing Signal Pathway by Inhibiting NF-κB Activation.

Authors:  Haiyan Xu; Chenhe Su; Angela Pearson; Christopher H Mody; Chunfu Zheng
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

Review 6.  Interferons and viruses: an evolutionary arms race of molecular interactions.

Authors:  Hans-Heinrich Hoffmann; William M Schneider; Charles M Rice
Journal:  Trends Immunol       Date:  2015-02-20       Impact factor: 16.687

7.  Nucleic acids potentiate Factor VII-activating protease (FSAP)-mediated cleavage of platelet-derived growth factor-BB and inhibition of vascular smooth muscle cell proliferation.

Authors:  Aya Shibamiya; Lars Muhl; Susanne Tannert-Otto; Klaus T Preissner; Sandip M Kanse
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

8.  Preconditioning with intravenous colitic cell-free DNA prevents DSS-colitis by altering TLR9-associated gene expression profile.

Authors:  Györgyi Műzes; Ferenc Sipos; István Fűri; Miklós Constantinovits; Sándor Spisák; Barnabás Wichmann; Gábor Valcz; Zsolt Tulassay; Béla Molnár
Journal:  Dig Dis Sci       Date:  2014-09-13       Impact factor: 3.199

9.  Intravenous administration of a single-dose free-circulating DNA of colitic origin improves severe murine DSS-colitis.

Authors:  Ferenc Sipos; Györgyi Műzes; István Fűri; Sándor Spisák; Barnabás Wichmann; Tiana M Germann; Miklós Constantinovits; Tibor Krenács; Zsolt Tulassay; Béla Molnár
Journal:  Pathol Oncol Res       Date:  2014-04-11       Impact factor: 3.201

Review 10.  Update on toll-like receptor-directed therapies for human disease.

Authors:  Kevin Tse; Anthony A Horner
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.